Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral grass pollen immunotherapy in HIV-positive adults with grass pollen allergy
2011-006251-11Phase 3Active
- Sponsor
- Luigi Sacco University Hospital
- Start
- Mar 2012
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of five-grass-pollen extract in grass pollen allergy, allergic rhinitis (AR) and allergic conjunctivitis (AC) (2 arms), sponsored by Luigi Sacco University Hospital. Primary endpoint: Safety evaluation through CD4 lymphocyte count and HIV-RNA. Started Mar 2012; status: active.
02
Drugs
five-grass-pollen extract
03
Conditions
grass pollen allergyallergic rhinitis (AR)allergic conjunctivitis (AC)
Beyond the preview
Go deeper on 2011-006251-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006251-11.